Gurská Soňa Ph.D.

Impact factor journals

IVASECHKO, I., A. LOZYNSKYI, J. SENKIV, P. ROSZCZENKO, Y. KOZAK, N. FINIUK, O. KLYUCHIVSKA, N. KASHCHAK, N. MANKO, Z. MASLYAK, D. LESYK, A. KARKHUT, S. POLOKVOVYCH, R. CZARNOMYSY, O. SZEWCZYK, A. KOZYTSKIY, O. KARPENKO, D. KHYLUK, A. GZELLA, K. BIELAWSKI, A. BIELAWSKA, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, R. STOIKA, R. LESYK
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone). European Journal of Medicinal Chemistry. 2023, 252, 115304, ISSN: 0223-5234, PMID: 37001390,
JURÁŠEK, M., J. ŘEHULKA, L. HRUBÁ, A. IVANOVA (NIKONENKO), S. GURSKÁ, O. MOKSHYNA, P. TROUSIL, K. HUML, P. POLISHCHUK, M. HAJDÚCH, P. DRAŠAR, P. DŽUBÁK
Triazole-based estradiol dimers prepared via CuAAC from 17α-ethinyl estradiol with five-atom linkers causing G2/M arrest and tubulin inhibition. Bioorganic Chemistry. 2023, 131(2023), 106334, ISSN: 0045-2068, PMID: 36592487,
VIDLAŘOVÁ, M., E. BERTA, P. PRASIL, A. PROKOPOVÁ, S. GURSKÁ, M. KHOYLOU, A. ŘEHULKOVÁ, P. KOUŘILOVÁ, J. CHUDÁČEK, M. SZKORUPA, J. KLEIN, J. ŠKARDA, J. SROVNAL, M. HAJDÚCH
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival. Translational Lung Cancer Research. 2022, 11(10), 2040-2050, ISSN: 2218-6751, PMID: 36386452,

Other reviewed journals

KONEČNÝ, P., S. GURSKÁ, P. ZNOJEK, E. SCHADICH, M. HAJDÚCH, P. DŽUBÁK
Reprofilování jako úspěšná strategie hledání nových léčiv. Farmakologická léčba. 2015, 4(10/2015), 12-18, ISSN: 1805-398X.

Book chapters

GURSKÁ, S.
Analysis of cytotoxicity by tetrazolium salt reduction test , 1.vyd., Olomouc, Palacky University, 2021, 10, 67-72, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

RNA ISOLATION KIT (Džubák)

Utility Model: CZ 35067. Granted: 18.5.2021. Ownership: Palacky University, Olomouc. Inventors: Džubák Petr, Hajdúch Marián, Gurská Soňa, Koudeláková Vladimíra, Jaworek Hana.

Status: Available

Master mentorship

Synek Vojtěch

Development of the assay for measurement of the CA activity and its implementation into HTS

Status: Graduated from 2018 to 2020.
Dostálová Kristýna

Cell-based assays for high-throughput screening in drug discovery

Status: Graduated from 2014 to 2016.
Voltemarová Tereza

Cytotoxicity profiling of new potentially bioactive compounds using high throughput screening (HTS)

Status: Graduated from 2019 to 2021.

Bachelor mentorship

Jamborová Petra

Establishment and characterization of anticancer drug resistant leukemic cell lines

Status: Ongoing from 2023.
Synek Vojtěch

Cytotoxicity tests for high-throughput drug discovery

Status: Graduated from 2014 to 2018.
Zabáková Dominika

Analysis of the cytotoxic effects of new chemical substances in HTS conditions

Status: Graduated from 2021 to 2021.

Open positions

Project: Drug repurposing for treatment and prevention of diseases
Supervisors: Hajdúch Marián M.D., Ph.D., Gurská Soňa Ph.D.
Available: 2
Intended for: Doctoral training